Yep. Sadly for us, I think the letter from the FDA reads...

Yep.
Sadly for us, I think the letter from the FDA reads something like this.

"See that little light on the horizon.?
That's your hope for a US clinical trial disappearing over it with its derrière on fire."

On a literal reading of the company's request for a trading halt, it reads that MVP has already received the feedback from the FDA..

"the Company is seeking the trading halt pending an announcement in relation to feedbackreceived from the FDA on MVP’s USA clinical hold response;"

If it was good news, I don't think they would need a trading halt.
They would just put it out there..
Rather, I think the request for a trading halt suggests that the folk at MVP are trying to figure out what residual hope that they can salvage from the FDA response.

As a holder, I hope it is otherwise, but I am pessimistic.

If on the other hand, MVP hasn't actually received the response yet, then obviously, all balls are still in the air.
But that's not the way it reads..

Cheers